Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2019

13.06.2019 | Thoracic Oncology

Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations

verfasst von: Mitsuro Kanda, MD, FACS, Masahiko Koike, MD, Chie Tanaka, MD, Daisuke Kobayashi, MD, Masamichi Hayashi, MD, FACS, Suguru Yamada, MD, FACS, Kenji Omae, PhD, Yasuhiro Kodera, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients undergoing subtotal esophagectomy for esophageal cancer frequently experience postoperative pneumonia. Development of preoperatively determined predictors for postoperative pneumonia will facilitate identifying high-risk patients and will assist with informing patients about their risk of postoperative pneumonia, enabling physicians to estimate with greater accuracy, will result in tailoring perioperative management.

Methods

Postoperative pneumonia was defined according to the revised Uniform Pneumonia Score. We analyzed the data for 355 patients to compare 32 potential predictive variables associated with postoperative pneumonia after subtotal esophagectomy.

Results

Forty-one patients (11.5%) had postoperative pneumonia. Preoperative cholinesterase (ChE) concentrations demonstrated the greatest area under the curve value (0.662) to predict postoperative pneumonia (optimal cutoff value = 217 IU/l). Univariate analysis identified a continuous value of preoperative ChE concentration as a significant risk factor for postoperative pneumonia (P = 0.0014). Multivariable analysis using factors potentially relevant to pneumonia revealed that preoperative ChE concentration was one of independent risk factors for pneumonia after esophagectomy (P = 0.008). Patients with low ChE concentrations were at increased risk of postoperative pneumonia in most patient subgroups. Moreover, the odds ratios of low ChE concentrations were highest in patients undergoing neoadjuvant treatment. A combination of preoperative serum ChE concentrations and Brinkman index stratified patients into low, intermediate, and high risk of postoperative pneumonia.

Conclusions

Our findings indicate that preoperative ChE concentrations, particularly in combination with Brinkman index, may serve simply as a determined predictor of pneumonia after subtotal esophagectomy and may facilitate physicians’ efforts to reduce the incidence of postoperative pneumonia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRefPubMed Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRefPubMed
3.
Zurück zum Zitat Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152–7.CrossRefPubMed Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152–7.CrossRefPubMed
4.
Zurück zum Zitat Molena D, Mungo B, Stem M, et al. Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis. Semin Thorac Cardiovasc Surg. 2014;26:287–94.CrossRefPubMed Molena D, Mungo B, Stem M, et al. Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis. Semin Thorac Cardiovasc Surg. 2014;26:287–94.CrossRefPubMed
5.
Zurück zum Zitat Yoshida N, Watanabe M, Baba Y, et al. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today. 2014;44:526–32.CrossRefPubMed Yoshida N, Watanabe M, Baba Y, et al. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today. 2014;44:526–32.CrossRefPubMed
6.
Zurück zum Zitat Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152–7.CrossRefPubMed Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152–7.CrossRefPubMed
7.
Zurück zum Zitat Saeki H, Tsutsumi S, Tajiri H, et al. Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg. 2017;265:527–33.CrossRefPubMed Saeki H, Tsutsumi S, Tajiri H, et al. Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg. 2017;265:527–33.CrossRefPubMed
8.
Zurück zum Zitat Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002;123:661–9.CrossRefPubMed Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002;123:661–9.CrossRefPubMed
9.
Zurück zum Zitat Akuzawa N, Naito H. Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a retrospective cross-sectional study. BMC Pulm Med. 2015;15:149.CrossRefPubMedPubMedCentral Akuzawa N, Naito H. Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a retrospective cross-sectional study. BMC Pulm Med. 2015;15:149.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wei R, Dong W, Shen H, et al. Predictive effects of lung function test on postoperative pneumonia in squamous esophageal cancer. Sci Rep. 2016;6:23636.CrossRefPubMedPubMedCentral Wei R, Dong W, Shen H, et al. Predictive effects of lung function test on postoperative pneumonia in squamous esophageal cancer. Sci Rep. 2016;6:23636.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8:545–53.CrossRefPubMed Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8:545–53.CrossRefPubMed
12.
Zurück zum Zitat Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, et al. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 2012;35:104–9.CrossRefPubMed Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, et al. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 2012;35:104–9.CrossRefPubMed
13.
Zurück zum Zitat Raymond DP, Seder CW, Wright CD, et al. Predictors of major morbidity or mortality after resection for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. Ann Thorac Surg. 2016;102:207–14.CrossRefPubMedPubMedCentral Raymond DP, Seder CW, Wright CD, et al. Predictors of major morbidity or mortality after resection for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. Ann Thorac Surg. 2016;102:207–14.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Biere SS, van Berge Henegouwen MI, Bonavina L, et al. Predictive factors for post-operative respiratory infections after esophagectomy for esophageal cancer: outcome of randomized trial. J Thorac Dis. 2017;9:S861–7.CrossRefPubMedPubMedCentral Biere SS, van Berge Henegouwen MI, Bonavina L, et al. Predictive factors for post-operative respiratory infections after esophagectomy for esophageal cancer: outcome of randomized trial. J Thorac Dis. 2017;9:S861–7.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol. 2016;113:678–84.CrossRefPubMed Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol. 2016;113:678–84.CrossRefPubMed
16.
Zurück zum Zitat Shiozaki A, Fujiwara H, Okamura H, et al. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;3:907–12.PubMedPubMedCentral Shiozaki A, Fujiwara H, Okamura H, et al. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;3:907–12.PubMedPubMedCentral
17.
Zurück zum Zitat Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefPubMed Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefPubMed
18.
Zurück zum Zitat Niwa Y, Koike M, Hattori M, et al. Short-term outcomes after conventional transthoracic esophagectomy. Nagoya J Med Sci. 2016;78:69–78.PubMedPubMedCentral Niwa Y, Koike M, Hattori M, et al. Short-term outcomes after conventional transthoracic esophagectomy. Nagoya J Med Sci. 2016;78:69–78.PubMedPubMedCentral
19.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed
20.
Zurück zum Zitat Weijs TJ, Seesing MF, van Rossum PS, et al. Internal and external validation of a multivariable model to define hospital-acquired pneumonia after esophagectomy. J Gastrointest Surg. 2016;20:680–7.CrossRefPubMedPubMedCentral Weijs TJ, Seesing MF, van Rossum PS, et al. Internal and external validation of a multivariable model to define hospital-acquired pneumonia after esophagectomy. J Gastrointest Surg. 2016;20:680–7.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat van der Sluis PC, Verhage RJ, van der Horst S, et al. A new clinical scoring system to define pneumonia following esophagectomy for cancer. Dig Surg. 2014;31:108–16.CrossRefPubMed van der Sluis PC, Verhage RJ, van der Horst S, et al. A new clinical scoring system to define pneumonia following esophagectomy for cancer. Dig Surg. 2014;31:108–16.CrossRefPubMed
22.
Zurück zum Zitat Kanda M, Mizuno A, Tanaka C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore). 2016;95:e3781.CrossRefPubMedPubMedCentral Kanda M, Mizuno A, Tanaka C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore). 2016;95:e3781.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Inaoka K, Kanda M, Uda H, et al. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2–4 gastric cancer. World J Gastroenterol. 2017;23:2519–26.CrossRefPubMedPubMedCentral Inaoka K, Kanda M, Uda H, et al. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2–4 gastric cancer. World J Gastroenterol. 2017;23:2519–26.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Tanaka Y, Kanda M, Tanaka C, et al. Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2–4 gastric cancer. Gastric Cancer. 2017;20:736–43.CrossRefPubMed Tanaka Y, Kanda M, Tanaka C, et al. Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2–4 gastric cancer. Gastric Cancer. 2017;20:736–43.CrossRefPubMed
25.
Zurück zum Zitat Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine—reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189–94.CrossRefPubMed Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine—reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189–94.CrossRefPubMed
26.
Zurück zum Zitat Nomura S, Tsujimoto H, Aosasa S, et al. Impact of angiotensin-converting enzyme 2 levels on postoperative pneumonia after esophagectomy. J Surg Res. 2018;224:200–6.CrossRefPubMed Nomura S, Tsujimoto H, Aosasa S, et al. Impact of angiotensin-converting enzyme 2 levels on postoperative pneumonia after esophagectomy. J Surg Res. 2018;224:200–6.CrossRefPubMed
27.
Zurück zum Zitat Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.CrossRefPubMed Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.CrossRefPubMed
28.
Zurück zum Zitat Montagnese C, Scalfi L, Signorini A, et al. Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders. Int J Eat Disord. 2007;40:746–50.CrossRefPubMed Montagnese C, Scalfi L, Signorini A, et al. Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders. Int J Eat Disord. 2007;40:746–50.CrossRefPubMed
29.
Zurück zum Zitat Santarpia L, Grandone I, Contaldo F, et al. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4:31–9.CrossRefPubMed Santarpia L, Grandone I, Contaldo F, et al. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4:31–9.CrossRefPubMed
30.
Zurück zum Zitat Cheng BN, Jin YL, Chen BQ, et al. Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection. Infect Dis Poverty. 2016;5:27.CrossRefPubMedPubMedCentral Cheng BN, Jin YL, Chen BQ, et al. Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection. Infect Dis Poverty. 2016;5:27.CrossRefPubMedPubMedCentral
31.
32.
Zurück zum Zitat Brzezinski RY, Fisher E, Cohen N, et al. Total serum cholinesterase activity predicts hemodynamic changes during exercise and associates with cardiac troponin detection in a sex-dependent manner. Mol Med. 2018;24:63.CrossRefPubMedPubMedCentral Brzezinski RY, Fisher E, Cohen N, et al. Total serum cholinesterase activity predicts hemodynamic changes during exercise and associates with cardiac troponin detection in a sex-dependent manner. Mol Med. 2018;24:63.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Konopke R, Kersting S, Bunk A, et al. Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis. 2009;24:687–97.CrossRefPubMed Konopke R, Kersting S, Bunk A, et al. Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis. 2009;24:687–97.CrossRefPubMed
34.
Zurück zum Zitat Donadon M, Cimino M, Procopio F, et al. Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma. Updates Surg. 2013;65:11–8.CrossRefPubMed Donadon M, Cimino M, Procopio F, et al. Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma. Updates Surg. 2013;65:11–8.CrossRefPubMed
35.
Zurück zum Zitat Chen T, Wang H, Wang H, et al. POSSUM and P-POSSUM as predictors of postoperative morbidity and mortality in patients undergoing hepato-biliary-pancreatic surgery: a meta-analysis. Ann Surg Oncol. 2013;20:2501–10.CrossRefPubMed Chen T, Wang H, Wang H, et al. POSSUM and P-POSSUM as predictors of postoperative morbidity and mortality in patients undergoing hepato-biliary-pancreatic surgery: a meta-analysis. Ann Surg Oncol. 2013;20:2501–10.CrossRefPubMed
36.
Zurück zum Zitat Meguid RA, Bronsert MR, Juarez-Colunga E, et al. Surgical risk preoperative assessment system (SURPAS): III. Accurate preoperative prediction of 8 adverse outcomes using 8 predictor variables. Ann Surg. 2016;264:23–31.CrossRefPubMed Meguid RA, Bronsert MR, Juarez-Colunga E, et al. Surgical risk preoperative assessment system (SURPAS): III. Accurate preoperative prediction of 8 adverse outcomes using 8 predictor variables. Ann Surg. 2016;264:23–31.CrossRefPubMed
37.
Zurück zum Zitat Takesue T, Takeuchi H, Ogura M, et al. A prospective randomized trial of enteral nutrition after thoracoscopic esophagectomy for esophageal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S802–9.CrossRefPubMed Takesue T, Takeuchi H, Ogura M, et al. A prospective randomized trial of enteral nutrition after thoracoscopic esophagectomy for esophageal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S802–9.CrossRefPubMed
39.
Zurück zum Zitat Kanda M, Murotani K, Tanaka H, et al. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. Cancer Med. 2018;7:2463–71.CrossRefPubMedPubMedCentral Kanda M, Murotani K, Tanaka H, et al. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. Cancer Med. 2018;7:2463–71.CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations
verfasst von
Mitsuro Kanda, MD, FACS
Masahiko Koike, MD
Chie Tanaka, MD
Daisuke Kobayashi, MD
Masamichi Hayashi, MD, FACS
Suguru Yamada, MD, FACS
Kenji Omae, PhD
Yasuhiro Kodera, MD, FACS
Publikationsdatum
13.06.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07512-7

Weitere Artikel der Ausgabe 11/2019

Annals of Surgical Oncology 11/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.